Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.1859 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1113 | 0.5489 | 0.5419 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1005 | 0.4835 | 0.4754 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0313 | 0.0652 | 0.0506 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0313 | 0.0652 | 0.0506 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0271 | 0.0396 | 0.0246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.148 | 0.7707 | 0.7671 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1007 | 0.4844 | 0.4763 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.1482 | 0.7716 | 0.768 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0484 | 0.1685 | 0.1481 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1102 | 0.5423 | 0.5351 |
Echinococcus granulosus | serine:threonine protein kinase SMG1 | 0.0356 | 0.0912 | 0.0689 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1005 | 0.4835 | 0.4754 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0356 | 0.0912 | 0.0689 |
Brugia malayi | FAT domain containing protein | 0.0271 | 0.0396 | 0.016 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0627 | 0.2551 | 0.2434 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0356 | 0.0912 | 0.077 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0253 | 0.0285 | 0.0133 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1007 | 0.4844 | 0.4763 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0356 | 0.0912 | 0.077 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0253 | 0.0285 | 0.0133 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.1859 | 1 | 1 |
Entamoeba histolytica | Phosphatidylinositol 3- and 4-kinase family | 0.0356 | 0.0912 | 0.0912 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0356 | 0.0912 | 0.0689 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0356 | 0.0912 | 0.077 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.148 | 0.7707 | 0.7671 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 0.0239 | 0.0087 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0627 | 0.2551 | 0.2434 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0313 | 0.0652 | 0.0652 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0627 | 0.2551 | 0.1803 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1859 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0503 | 0.1799 | 0.1671 |
Echinococcus granulosus | serine protein kinase ATM | 0.0356 | 0.0912 | 0.0689 |
Echinococcus multilocularis | PIK kinase, FAT and Armadillo domain containing protein | 0.0271 | 0.0396 | 0.016 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.148 | 0.7707 | 0.7671 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0627 | 0.2551 | 0.2434 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.1859 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0627 | 0.2551 | 0.1803 |
Entamoeba histolytica | protein kinase rad3, putative | 0.0356 | 0.0912 | 0.0912 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0627 | 0.2551 | 0.2368 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1113 | 0.5489 | 0.5419 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0627 | 0.2551 | 0.2243 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0627 | 0.2551 | 0.2434 |
Giardia lamblia | GTOR | 0.1859 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0356 | 0.0912 | 0.077 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.1859 | 1 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0776 | 0.3447 | 0.279 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0627 | 0.2551 | 0.2434 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0396 | 0.1154 | 0.1016 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0313 | 0.0652 | 0.0506 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0396 | 0.1154 | 0.039 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.1859 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.1859 | 1 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.1859 | 1 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.1482 | 0.7716 | 0.7487 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0484 | 0.1685 | 0.1481 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0274 | 0.0413 | 0.0413 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0627 | 0.2551 | 0.2434 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0356 | 0.0912 | 0.0689 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.1859 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0356 | 0.0912 | 0.077 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.1154 | 0.1016 |
Loa Loa (eye worm) | hypothetical protein | 0.0271 | 0.0396 | 0.0246 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1209 | 0.6068 | 0.6006 |
Entamoeba histolytica | hypothetical protein | 0.0274 | 0.0413 | 0.0413 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.1859 | 1 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0627 | 0.2551 | 0.2368 |
Schistosoma mansoni | fkbp-rapamycin associated protein | 0.0356 | 0.0912 | 0.0537 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0627 | 0.2551 | 0.2368 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0484 | 0.1685 | 0.1342 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1113 | 0.5489 | 0.5419 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1005 | 0.4835 | 0.4754 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1102 | 0.5423 | 0.5351 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.1384 | 0.7128 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0627 | 0.2551 | 0.2434 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.1482 | 0.7716 | 0.6934 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0313 | 0.0652 | 0.0506 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0356 | 0.0912 | 0.0537 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1249 | 0.631 | 0.6252 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.148 | 0.7707 | 0.7671 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0313 | 0.0652 | 0.0423 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1007 | 0.4844 | 0.4763 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0356 | 0.0912 | 0.077 |
Echinococcus multilocularis | serine:threonine protein kinase SMG1 | 0.0356 | 0.0912 | 0.0689 |
Entamoeba histolytica | hypothetical protein | 0.0356 | 0.0912 | 0.0912 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1007 | 0.4844 | 0.4763 |
Echinococcus granulosus | PIK kinase FAT and Armadillo domain containing protein | 0.0271 | 0.0396 | 0.016 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1384 | 0.7128 | 0.7083 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.1859 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0882 | 0.4092 | 0.35 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.148 | 0.7707 | 0.7671 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1859 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.1859 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0445 | 0.1445 | 0.1312 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1859 | 1 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.1859 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0627 | 0.2551 | 0.2434 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0313 | 0.0652 | 0.0506 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.1588 | 0.8361 | 0.8336 |
Loa Loa (eye worm) | hypothetical protein | 0.0378 | 0.1041 | 0.0901 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Communicating cells (functional) | = 9.5 | Tested for anticancer activity by measuring the number of communicating cells using gap junctional communication assay at 10e-6 M (P>0.001) | ChEMBL. | 8230100 |
Control (functional) | = 0 % | Inhibition of neoplastic transformation at a concentration of 10e-6 M | ChEMBL. | 8230100 |
Control (functional) | = 0 % | Inhibition of neoplastic transformation at a concentration of 10e-6 M | ChEMBL. | 8230100 |
Control (functional) | = 24 % | Inhibition of neoplastic transformation at a concentration of 10e-8 M | ChEMBL. | 8230100 |
Control (functional) | = 24 % | The compound was tested for inhibition of neoplastic transformation,at a concentration of 10e-10 M | ChEMBL. | 8230100 |
Control (functional) | = 24 % | Inhibition of neoplastic transformation at a concentration of 10e-8 M | ChEMBL. | 8230100 |
Control (functional) | = 24 % | The compound was tested for inhibition of neoplastic transformation,at a concentration of 10e-10 M | ChEMBL. | 8230100 |
Control (functional) | = 66 % | Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-6 M | ChEMBL. | 8230100 |
Control (functional) | = 66 % | Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-6 M | ChEMBL. | 8230100 |
Control (functional) | = 75 % | Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-8 M | ChEMBL. | 8230100 |
Control (functional) | = 75 % | Toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-10 M | ChEMBL. | 8230100 |
Control (functional) | = 75 % | Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-8 M | ChEMBL. | 8230100 |
Control (functional) | = 75 % | Toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-10 M | ChEMBL. | 8230100 |
Foci/dish (functional) | = 0 | Inhibition of neoplastic transformation was measured by measuring the transformed foci per dish at 10e-6 M | ChEMBL. | 8230100 |
Foci/dish (functional) | = 0.16 | Tested for inhibition of neoplastic transformation by measuring the transformed foci per dish at 10e-8 M | ChEMBL. | 8230100 |
Foci/dish (functional) | = 0.16 | Tested for inhibition of neoplastic transformation by measuring the transformed foci per dish at 10e-10 M | ChEMBL. | 8230100 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.